Cumberland Partners Ltd grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 60,974 shares of the healthcare conglomerate's stock after purchasing an additional 9,718 shares during the period. UnitedHealth Group makes up 2.5% of Cumberland Partners Ltd's holdings, making the stock its 11th largest position. Cumberland Partners Ltd's holdings in UnitedHealth Group were worth $35,650,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the period. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 47 shares during the period. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $32,000. Finally, Delos Wealth Advisors LLC grew its holdings in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate's stock valued at $30,000 after purchasing an additional 53 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
Several equities analysts have recently weighed in on UNH shares. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald raised their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a research report on Wednesday, October 16th. StockNews.com downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, October 24th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 16th. Finally, Stephens reduced their price objective on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $615.53.
View Our Latest Stock Report on UNH
Shares of NYSE UNH traded down $7.87 during trading on Tuesday, reaching $617.38. The stock had a trading volume of 597,431 shares, compared to its average volume of 3,885,795. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The business's 50-day moving average price is $582.63 and its 200-day moving average price is $546.78. The company has a market cap of $568.16 billion, a P/E ratio of 40.73, a PEG ratio of 1.81 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. During the same period in the previous year, the firm posted $6.56 earnings per share. The company's revenue was up 9.2% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. UnitedHealth Group's dividend payout ratio is currently 54.72%.
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.